ABSTRACT. We sought to identify instruments assessing sleep quality that measure the domains of sleep applicable to rheumatoid arthritis (RA) patients and are feasible to use and have appropriate reliability, validity, and responsiveness properties. A systematic review of sleep instruments was conducted. In particular, domains related to sleep that were assessed in the instruments were identified and evaluated. Feasibility characteristics and psychometric properties of instruments were reviewed. At OMERACT 9, the preparatory work was described at the plenary session of the Patient Perspective Workshop, and the tasks of 3 breakout groups in ranking and scoring the domains and sleep instruments were outlined. Each breakout group considered different aspects of sleep: sleep domains, feasibility, and psychometric properties. The rapporteur for each breakout group reported back to the plenary on the domains and sleep instruments that achieved the highest rank/score. The systematic review identified 45 sleep instruments of interest. Based on these instruments, 14 domains of sleep were identified. The top ranked domains were: Sleep Adequacy (1), Sleep Maintenance (2), Sleep Initiation (3) and Daytime Functioning (4). The top ranked instruments on feasibility were: Athens Insomnia Scale (2.3), Medical Outcome Study (MOS) Sleep (4.0), Insomnia Severity Index (4.9), and Women's Health Insomnia Rating Scale (5.5). The highest scored instruments on psychometric properties were: Athens Insomnia Scale (13.6), Sleep Assessment Questionnaire (13), Pittsburgh Sleep Diary (12), and MOS Sleep (11). Sleep domains have been reviewed, and several sleep instruments have been identified. These instruments should be considered for use in planned clinical trials of RA patients to assess their applicability.
Patient reported outcomes provide an assessment of a patient's health, well-being, and treatment from the patient's perspective. Sleep quality and fatigue have been identified at different OMERACT meetings as important aspects of the health and well-being of patients with arthritis. In particular, at the OMERACT 6 workshop for developing an operational definition of low disease activity state for rheumatoid arthritis (RA), the patient group emphasized fatigue and sleep as important issues in RA 1 ; and at a patient perspective workshop at OMERACT 7 the question of assessing outcomes of treatment for arthritis from the perspective of those who experience the disease themselves was addressed with a particular emphasis placed on fatigue 2 . The focus here is on sleep in patients with RA. Individuals with a variety of common medical illnesses including arthritis frequently experience sleep disturbances. It is recognized that medical illnesses can adversely affect sleep quality, and that pain, infection, and inflammation can induce symptoms of excessive daytime sleepiness and fatigue [3] [4] [5] [6] . In particular, this is true for patients with RA [7] [8] [9] [10] .
Questionnaires are often the instrument of choice to assess sleep, and in using a particular instrument attention must be given to 3 aspects: the domains of sleep that are evaluated, the feasibility of completing the questionnaire, and the psychometric or measurement properties of the instrument.
First Second, feasibility relates to the efficiency of the administration of the instrument and the resulting burden of completing the instrument. In particular, this includes both the number of questions and the difficulty in answering the questionnaires based on the questionnaire format, response key, and language level. It is generally known that response rates and validity of the answers are directly related to feasibility 14 . Ideally, the instrument should have a short administration time, low reading level required, and be easily understood.
Third, the psychometric properties of an instrument of interest refer to the reliability, validity, and sensitivity of the instrument. Reliability is concerned with whether the instrument consistently measures the characteristic of interest, validity relates to whether the instrument measures what it is supposed to measure, and sensitivity to change is concerned with whether the instrument can detect small but clinically important changes. These properties are of particular importance when subjective reports of health status is one of the primary outcomes of the trial.
For properly assessing sleep for patients with RA, 3 key aspects of any sleep instrument need to be considered: the domains, feasibility, and psychometric properties. In terms of the OMERACT filter: truth relates to the domains assessed (content validity) and psychometric properties of validity and reliability; feasibility is directly related to administrative burden and applicability; and discrimination relates to the psychometric property of sensitivity or responsiveness. The first step is a systematic review of the literature for potential sleep instruments that could be used and then attaining consensus on which instruments should be further considered. The objective of our workshop was to identify instruments assessing sleep quality that measure domains of sleep applicable to RA patients and are feasible to use and have appropriate reliability, validity and responsiveness properties.
PREPARING FOR THE PATIENT PERSPECTIVE WORKSHOP ON SLEEP
In preparing for OMERACT 9, the working group met periodically by teleconference and E-mail in addition to in-person meetings at the American College of Rheumatology and European League Against Rheumatism conferences in 2007. A systematic literature review of instruments designed to assess various aspects of sleep was conducted in January 2007, and during 2007 these instruments were evaluated on their response characteristics, psychometric properties, and domains of sleep assessed. The deliverables for OMERACT 9 were to present the results of the systematic literature review on sleep instruments and their truth and feasibility of use in RA. The objective for OMERACT 9 was to select candidate instruments based on truth, discrimination, and feasibility that measure sleep domains of interest. Systematic review of sleep instruments. In conducting the systematic review the methodology of the Cochrane Collaboration was adhered to and the following steps were undertaken: a comprehensive literature search was conducted (keywords and MeSH terms: sleep, insomnia, sleep disorders, questionnaires, interviews, health surveys, psychometrics, health status, quality of life); citations and articles were selected using predefined criteria by 2 independent reviewers; information on the instruments was extracted from the articles using 2 independent reviewers; characteristics of the instruments were summarized including format properties, number of items, response format, timeline, and psychometric properties (reliability, validity, responsiveness). The literature search included: Medline (1966 to January 2007), PsychINFO (1806 to January 2007), Web-based databases (MAPI Research Institute and Educational Testing Service Test Collection), sleep assessment textbook chapters, bibliographies of sleep research, and review articles. Self-report instruments designed to assess sleep and sleep disorders in adults were selected. Instruments developed to measure sleep disruption secondary to other medical conditions (e.g., Parkinson's disease, sleep apnea) were excluded, with the exception of chronic pain.
The search resulted in 3751 citations from Medline (1966 to January 2007) and 174 citations from PsychINFO (1806 to January 2007). After applying the selection criteria, 45 instruments were identified that assessed a variety of domains related to sleep (Table 1) . In particular, the domains related to sleep that were assessed in the sleep instruments were identified and summarized, their applicability to chronic diseases, and in particular RA, were evaluated, and the psychometric properties and feasibility aspects of the instruments were reviewed.
The various domains related to sleep that were assessed in the sleep instruments identified in the systematic review were itemized and summarized (Table 2) . Fourteen domains were identified and presented at the EULAR 2007 conference. At a meeting of the working group at EULAR 2007, the applicability of these domains to chronic diseases, and in particular RA, was evaluated and confirmed. Also, the response characteristics and psychometric properties of the instruments were identified and summarized and, in preparation for OMERACT 9, a Delphi process reduced the number of instruments for consideration at OMERACT to 15 instruments. Selection of the instruments followed a similar process that would be used at the OMERACT meeting. The response characteristics of the instruments are summarized in Table 3 . The number of items typically ranged from 1 to 30 items, the response format was usually a Likert scale (4 or 5 point) or visual analog scale, and the timeline ranged from "recent" to 3 months. Most of the instruments were multidomain, and a summary of their psychometric properties based on the primary report of the instrument is provided in Appendix A. Timeline: The present; 7 statements from which subjects pick the one that best describes their state of sleepiness at that time Women's Health Initiative Timeline: Past 4 weeks; 5 items; 5 point scale Insomnia Rating Scale reviewed 5 instruments. After their review, each subgroup provided opinions on the instruments they reviewed, and the breakout group chairs coordinated a discussion among all the breakout group participants and reached an accord on the scoring of the instruments (with a high score indicating good psychometric properties). The 4 highest scored instruments were: Athens Insomnia Scale, 13.6; Sleep Assessment Questionnaire, 13.0; Pittsburgh Sleep Diary, 12.0; MOS Sleep Measure, 11.0.
BREAKOUT GROUP SESSIONS FOR THE PATIENT PERSPECTIVE WORKSHOP ON SLEEP

CONSENSUS BASED ON SLEEP DOMAINS, FEASIBILITY AND PSYCHOMETRIC PROPERTIES
Based on results from the 3 breakout groups (sleep domains considered most important, highest ranked sleep instruments on feasibility, and the highest scored sleep instruments on psychometric properties), the 4 sleep instruments identified for further consideration were the Athens Insomnia Scale, the MOS Sleep Measure, the Pittsburgh Sleep Diary and the Women's Health Insomnia Rating Scale (Table 4 ). Only the Athens Insomnia Scale assessed each of the top 4 sleep domains, and the MOS Sleep Measure and the Pittsburgh Sleep Diary assessed 3 of the domains and partially assessed the fourth domain of daytime functioning. Although the Pittsburgh Sleep Diary scored high on truth, it is difficult to complete and ranked low on feasibility. On the other hand, the Women's Health Insomnia Rating Scale was easy to complete and so ranked high on feasibility but did not score high on truth. Both the Athens Insomnia Scale and the MOS Sleep Measure scored high on truth and ranked high on feasibility.
In summary, sleep instruments have been evaluated on the domains assessed, feasibility, and psychometric properties. In terms of the OMERACT filter: truth relates to the domains assessed (content validity) and psychometric properties of validity and reliability; feasibility is directly related to administrative burden and applicability; and discrimination relates to the psychometric property of sensitivity or responsiveness.
A number of domains related to sleep have been reviewed, and several sleep instruments have been identified that may be applicable to RA patients, namely: Athens Insomnia Scale, the MOS Sleep Measure, the Pittsburgh Sleep Diary, and the Women's Health Insomnia Rating Scale. To further evaluate the sleep instruments identified, they should be considered in planned clinical trials of RA patients to assess their applicability. To further establish acceptability and applicability of the domains and the specific instruments, a Delphi exercise involving RA patients to further understand sleep quality from their perspective should be performed. 
